nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Acute coronary syndrome—Vincristine—colon cancer	0.00405	0.00405	CcSEcCtD
Frovatriptan—Myocardial infarction—Vincristine—colon cancer	0.00403	0.00403	CcSEcCtD
Frovatriptan—Stomatitis—Vincristine—colon cancer	0.00401	0.00401	CcSEcCtD
Frovatriptan—Polyuria—Capecitabine—colon cancer	0.00396	0.00396	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Irinotecan—colon cancer	0.00395	0.00395	CcSEcCtD
Frovatriptan—Myocardial infarction—Irinotecan—colon cancer	0.00392	0.00392	CcSEcCtD
Frovatriptan—Stomatitis—Irinotecan—colon cancer	0.0039	0.0039	CcSEcCtD
Frovatriptan—Vascular purpura—Capecitabine—colon cancer	0.00389	0.00389	CcSEcCtD
Frovatriptan—Eye pain—Capecitabine—colon cancer	0.00385	0.00385	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Fluorouracil—colon cancer	0.00378	0.00378	CcSEcCtD
Frovatriptan—Myocardial infarction—Fluorouracil—colon cancer	0.00376	0.00376	CcSEcCtD
Frovatriptan—Stomatitis—Fluorouracil—colon cancer	0.00374	0.00374	CcSEcCtD
Frovatriptan—Conjunctivitis—Fluorouracil—colon cancer	0.00373	0.00373	CcSEcCtD
Frovatriptan—Hot flush—Capecitabine—colon cancer	0.00372	0.00372	CcSEcCtD
Frovatriptan—Amnesia—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Frovatriptan—Menopausal symptoms—Capecitabine—colon cancer	0.00369	0.00369	CcSEcCtD
Frovatriptan—Hypoaesthesia—Vincristine—colon cancer	0.00367	0.00367	CcSEcCtD
Frovatriptan—Bradycardia—Irinotecan—colon cancer	0.00366	0.00366	CcSEcCtD
Frovatriptan—Thirst—Capecitabine—colon cancer	0.00365	0.00365	CcSEcCtD
Frovatriptan—Urinary tract disorder—Vincristine—colon cancer	0.00365	0.00365	CcSEcCtD
Frovatriptan—Dermatitis bullous—Capecitabine—colon cancer	0.00364	0.00364	CcSEcCtD
Frovatriptan—Urethral disorder—Vincristine—colon cancer	0.00362	0.00362	CcSEcCtD
Frovatriptan—Epistaxis—Fluorouracil—colon cancer	0.00362	0.00362	CcSEcCtD
Frovatriptan—Haemoglobin—Irinotecan—colon cancer	0.00361	0.00361	CcSEcCtD
Frovatriptan—Purpura—Capecitabine—colon cancer	0.00361	0.00361	CcSEcCtD
Frovatriptan—Rhinitis—Irinotecan—colon cancer	0.0036	0.0036	CcSEcCtD
Frovatriptan—Sinusitis—Fluorouracil—colon cancer	0.0036	0.0036	CcSEcCtD
Frovatriptan—Haemorrhage—Irinotecan—colon cancer	0.00359	0.00359	CcSEcCtD
Frovatriptan—Pain in extremity—Capecitabine—colon cancer	0.00348	0.00348	CcSEcCtD
Frovatriptan—Osteoarthritis—Capecitabine—colon cancer	0.00348	0.00348	CcSEcCtD
Frovatriptan—Visual impairment—Irinotecan—colon cancer	0.00346	0.00346	CcSEcCtD
Frovatriptan—Haemoglobin—Fluorouracil—colon cancer	0.00346	0.00346	CcSEcCtD
Frovatriptan—Rhinitis—Fluorouracil—colon cancer	0.00345	0.00345	CcSEcCtD
Frovatriptan—Haemorrhage—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Frovatriptan—Hypoaesthesia—Fluorouracil—colon cancer	0.00343	0.00343	CcSEcCtD
Frovatriptan—Migraine—Capecitabine—colon cancer	0.00342	0.00342	CcSEcCtD
Frovatriptan—Pharyngitis—Fluorouracil—colon cancer	0.00342	0.00342	CcSEcCtD
Frovatriptan—Flushing—Irinotecan—colon cancer	0.00334	0.00334	CcSEcCtD
Frovatriptan—Mood swings—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Frovatriptan—Ataxia—Capecitabine—colon cancer	0.00327	0.00327	CcSEcCtD
Frovatriptan—Dehydration—Capecitabine—colon cancer	0.00323	0.00323	CcSEcCtD
Frovatriptan—Mental disorder—Vincristine—colon cancer	0.00323	0.00323	CcSEcCtD
Frovatriptan—Chills—Irinotecan—colon cancer	0.00323	0.00323	CcSEcCtD
Frovatriptan—Urine output increased—Methotrexate—colon cancer	0.00322	0.00322	CcSEcCtD
Frovatriptan—Arrhythmia—Irinotecan—colon cancer	0.00321	0.00321	CcSEcCtD
Frovatriptan—Back pain—Vincristine—colon cancer	0.00311	0.00311	CcSEcCtD
Frovatriptan—Flatulence—Irinotecan—colon cancer	0.00308	0.00308	CcSEcCtD
Frovatriptan—Arrhythmia—Fluorouracil—colon cancer	0.00308	0.00308	CcSEcCtD
Frovatriptan—Muscular weakness—Capecitabine—colon cancer	0.00307	0.00307	CcSEcCtD
Frovatriptan—Back pain—Irinotecan—colon cancer	0.00303	0.00303	CcSEcCtD
Frovatriptan—Muscle spasms—Irinotecan—colon cancer	0.00301	0.00301	CcSEcCtD
Frovatriptan—Dysphagia—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Frovatriptan—Agitation—Vincristine—colon cancer	0.00295	0.00295	CcSEcCtD
Frovatriptan—Polyuria—Methotrexate—colon cancer	0.00295	0.00295	CcSEcCtD
Frovatriptan—Sweating increased—Capecitabine—colon cancer	0.00293	0.00293	CcSEcCtD
Frovatriptan—Ill-defined disorder—Irinotecan—colon cancer	0.0029	0.0029	CcSEcCtD
Frovatriptan—Vertigo—Vincristine—colon cancer	0.00289	0.00289	CcSEcCtD
Frovatriptan—Malaise—Irinotecan—colon cancer	0.00282	0.00282	CcSEcCtD
Frovatriptan—Vertigo—Irinotecan—colon cancer	0.00281	0.00281	CcSEcCtD
Frovatriptan—Syncope—Irinotecan—colon cancer	0.00281	0.00281	CcSEcCtD
Frovatriptan—Convulsion—Vincristine—colon cancer	0.00278	0.00278	CcSEcCtD
Frovatriptan—Loss of consciousness—Irinotecan—colon cancer	0.00275	0.00275	CcSEcCtD
Frovatriptan—Myalgia—Vincristine—colon cancer	0.00274	0.00274	CcSEcCtD
Frovatriptan—Depression—Capecitabine—colon cancer	0.00267	0.00267	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Frovatriptan—Discomfort—Irinotecan—colon cancer	0.00263	0.00263	CcSEcCtD
Frovatriptan—Myocardial infarction—Capecitabine—colon cancer	0.00263	0.00263	CcSEcCtD
Frovatriptan—Anaphylactic shock—Vincristine—colon cancer	0.00262	0.00262	CcSEcCtD
Frovatriptan—Stomatitis—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Frovatriptan—Conjunctivitis—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Frovatriptan—Convulsion—Fluorouracil—colon cancer	0.0026	0.0026	CcSEcCtD
Frovatriptan—Osteoarthritis—Methotrexate—colon cancer	0.00259	0.00259	CcSEcCtD
Frovatriptan—Confusional state—Irinotecan—colon cancer	0.00257	0.00257	CcSEcCtD
Frovatriptan—Anaphylactic shock—Irinotecan—colon cancer	0.00255	0.00255	CcSEcCtD
Frovatriptan—Myalgia—Fluorouracil—colon cancer	0.00255	0.00255	CcSEcCtD
Frovatriptan—Chest pain—Fluorouracil—colon cancer	0.00255	0.00255	CcSEcCtD
Frovatriptan—Hyperhidrosis—Vincristine—colon cancer	0.00253	0.00253	CcSEcCtD
Frovatriptan—Epistaxis—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Frovatriptan—Discomfort—Fluorouracil—colon cancer	0.00252	0.00252	CcSEcCtD
Frovatriptan—Shock—Irinotecan—colon cancer	0.00251	0.00251	CcSEcCtD
Frovatriptan—Anorexia—Vincristine—colon cancer	0.0025	0.0025	CcSEcCtD
Frovatriptan—Hyperhidrosis—Irinotecan—colon cancer	0.00247	0.00247	CcSEcCtD
Frovatriptan—Confusional state—Fluorouracil—colon cancer	0.00247	0.00247	CcSEcCtD
Frovatriptan—Mood swings—Methotrexate—colon cancer	0.00245	0.00245	CcSEcCtD
Frovatriptan—Bradycardia—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Frovatriptan—Anaphylactic shock—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Frovatriptan—Anorexia—Irinotecan—colon cancer	0.00243	0.00243	CcSEcCtD
Frovatriptan—Ataxia—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Frovatriptan—Haemoglobin—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Frovatriptan—Rhinitis—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Frovatriptan—Haemorrhage—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Frovatriptan—Hypoaesthesia—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Vincristine—colon cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Pharyngitis—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Tachycardia—Fluorouracil—colon cancer	0.00239	0.00239	CcSEcCtD
Frovatriptan—Urinary tract disorder—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Frovatriptan—Insomnia—Vincristine—colon cancer	0.00237	0.00237	CcSEcCtD
Frovatriptan—Urethral disorder—Capecitabine—colon cancer	0.00236	0.00236	CcSEcCtD
Frovatriptan—Paraesthesia—Vincristine—colon cancer	0.00235	0.00235	CcSEcCtD
Frovatriptan—Anorexia—Fluorouracil—colon cancer	0.00233	0.00233	CcSEcCtD
Frovatriptan—Visual impairment—Capecitabine—colon cancer	0.00232	0.00232	CcSEcCtD
Frovatriptan—Insomnia—Irinotecan—colon cancer	0.00231	0.00231	CcSEcCtD
Frovatriptan—Paraesthesia—Irinotecan—colon cancer	0.00229	0.00229	CcSEcCtD
Frovatriptan—Decreased appetite—Vincristine—colon cancer	0.00228	0.00228	CcSEcCtD
Frovatriptan—Dyspnoea—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Frovatriptan—Somnolence—Irinotecan—colon cancer	0.00227	0.00227	CcSEcCtD
Frovatriptan—Fatigue—Vincristine—colon cancer	0.00226	0.00226	CcSEcCtD
Frovatriptan—Dyspepsia—Irinotecan—colon cancer	0.00225	0.00225	CcSEcCtD
Frovatriptan—Tinnitus—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Frovatriptan—Pain—Vincristine—colon cancer	0.00224	0.00224	CcSEcCtD
Frovatriptan—Constipation—Vincristine—colon cancer	0.00224	0.00224	CcSEcCtD
Frovatriptan—Flushing—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00223	0.00223	CcSEcCtD
Frovatriptan—Decreased appetite—Irinotecan—colon cancer	0.00222	0.00222	CcSEcCtD
Frovatriptan—Insomnia—Fluorouracil—colon cancer	0.00221	0.00221	CcSEcCtD
Frovatriptan—Fatigue—Irinotecan—colon cancer	0.0022	0.0022	CcSEcCtD
Frovatriptan—Paraesthesia—Fluorouracil—colon cancer	0.0022	0.0022	CcSEcCtD
Frovatriptan—Pain—Irinotecan—colon cancer	0.00218	0.00218	CcSEcCtD
Frovatriptan—Constipation—Irinotecan—colon cancer	0.00218	0.00218	CcSEcCtD
Frovatriptan—Dyspnoea—Fluorouracil—colon cancer	0.00218	0.00218	CcSEcCtD
Frovatriptan—Somnolence—Fluorouracil—colon cancer	0.00217	0.00217	CcSEcCtD
Frovatriptan—Chills—Capecitabine—colon cancer	0.00216	0.00216	CcSEcCtD
Frovatriptan—Dyspepsia—Fluorouracil—colon cancer	0.00215	0.00215	CcSEcCtD
Frovatriptan—Arrhythmia—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Vincristine—colon cancer	0.00214	0.00214	CcSEcCtD
Frovatriptan—Decreased appetite—Fluorouracil—colon cancer	0.00213	0.00213	CcSEcCtD
Frovatriptan—Mental disorder—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Frovatriptan—Feeling abnormal—Irinotecan—colon cancer	0.0021	0.0021	CcSEcCtD
Frovatriptan—Malnutrition—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Frovatriptan—Pain—Fluorouracil—colon cancer	0.00209	0.00209	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Irinotecan—colon cancer	0.00209	0.00209	CcSEcCtD
Frovatriptan—Abdominal pain—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Frovatriptan—Body temperature increased—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Frovatriptan—Flatulence—Capecitabine—colon cancer	0.00206	0.00206	CcSEcCtD
Frovatriptan—Dysgeusia—Capecitabine—colon cancer	0.00205	0.00205	CcSEcCtD
Frovatriptan—Back pain—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Frovatriptan—Body temperature increased—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Frovatriptan—Abdominal pain—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Frovatriptan—Feeling abnormal—Fluorouracil—colon cancer	0.00202	0.00202	CcSEcCtD
Frovatriptan—Muscle spasms—Capecitabine—colon cancer	0.00201	0.00201	CcSEcCtD
Frovatriptan—Depression—Methotrexate—colon cancer	0.00199	0.00199	CcSEcCtD
Frovatriptan—Tremor—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Frovatriptan—Stomatitis—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Frovatriptan—Ill-defined disorder—Capecitabine—colon cancer	0.00194	0.00194	CcSEcCtD
Frovatriptan—Conjunctivitis—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Frovatriptan—Body temperature increased—Fluorouracil—colon cancer	0.00193	0.00193	CcSEcCtD
Frovatriptan—Hypersensitivity—Vincristine—colon cancer	0.00193	0.00193	CcSEcCtD
Frovatriptan—Malaise—Capecitabine—colon cancer	0.00189	0.00189	CcSEcCtD
Frovatriptan—Epistaxis—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Vertigo—Capecitabine—colon cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Hypersensitivity—Irinotecan—colon cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Asthenia—Vincristine—colon cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Syncope—Capecitabine—colon cancer	0.00188	0.00188	CcSEcCtD
Frovatriptan—Palpitations—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Frovatriptan—Loss of consciousness—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Frovatriptan—Asthenia—Irinotecan—colon cancer	0.00183	0.00183	CcSEcCtD
Frovatriptan—Hypersensitivity—Fluorouracil—colon cancer	0.0018	0.0018	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Frovatriptan—Diarrhoea—Vincristine—colon cancer	0.00179	0.00179	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Frovatriptan—Arthralgia—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Chest pain—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Myalgia—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Anxiety—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Frovatriptan—Discomfort—Capecitabine—colon cancer	0.00176	0.00176	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—colon cancer	0.00176	0.00176	CcSEcCtD
Frovatriptan—Diarrhoea—Irinotecan—colon cancer	0.00175	0.00175	CcSEcCtD
Frovatriptan—Dry mouth—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Frovatriptan—Dizziness—Vincristine—colon cancer	0.00173	0.00173	CcSEcCtD
Frovatriptan—Pruritus—Fluorouracil—colon cancer	0.00173	0.00173	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—colon cancer	0.00173	0.00173	CcSEcCtD
Frovatriptan—Confusional state—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Frovatriptan—Dizziness—Irinotecan—colon cancer	0.00169	0.00169	CcSEcCtD
Frovatriptan—Shock—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Frovatriptan—Diarrhoea—Fluorouracil—colon cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Tachycardia—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Vomiting—Vincristine—colon cancer	0.00167	0.00167	CcSEcCtD
Frovatriptan—Hyperhidrosis—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Frovatriptan—Headache—Vincristine—colon cancer	0.00164	0.00164	CcSEcCtD
Frovatriptan—Anorexia—Capecitabine—colon cancer	0.00163	0.00163	CcSEcCtD
Frovatriptan—Vomiting—Irinotecan—colon cancer	0.00162	0.00162	CcSEcCtD
Frovatriptan—Dizziness—Fluorouracil—colon cancer	0.00162	0.00162	CcSEcCtD
Frovatriptan—Chills—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Frovatriptan—Headache—Irinotecan—colon cancer	0.0016	0.0016	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Frovatriptan—Nausea—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Frovatriptan—Vomiting—Fluorouracil—colon cancer	0.00156	0.00156	CcSEcCtD
Frovatriptan—Insomnia—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Frovatriptan—Paraesthesia—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Frovatriptan—Headache—Fluorouracil—colon cancer	0.00153	0.00153	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Frovatriptan—Dyspnoea—Capecitabine—colon cancer	0.00152	0.00152	CcSEcCtD
Frovatriptan—Nausea—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Frovatriptan—Dyspepsia—Capecitabine—colon cancer	0.0015	0.0015	CcSEcCtD
Frovatriptan—Decreased appetite—Capecitabine—colon cancer	0.00149	0.00149	CcSEcCtD
Frovatriptan—Fatigue—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Frovatriptan—Pain—Capecitabine—colon cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Constipation—Capecitabine—colon cancer	0.00146	0.00146	CcSEcCtD
Frovatriptan—Nausea—Fluorouracil—colon cancer	0.00145	0.00145	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Frovatriptan—Feeling abnormal—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—colon cancer	0.00141	0.00141	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Frovatriptan—Body temperature increased—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Abdominal pain—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—colon cancer	0.00135	0.00135	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—colon cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Frovatriptan—Hypersensitivity—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Asthenia—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Pruritus—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Diarrhoea—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Dizziness—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—colon cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Pain—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Vomiting—Capecitabine—colon cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Headache—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Nausea—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—colon cancer	0.000937	0.000937	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—colon cancer	0.000913	0.000913	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—colon cancer	0.0009	0.0009	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—colon cancer	0.000871	0.000871	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—colon cancer	0.000841	0.000841	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—colon cancer	0.000809	0.000809	CcSEcCtD
Frovatriptan—Headache—Methotrexate—colon cancer	0.000797	0.000797	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—colon cancer	0.000756	0.000756	CcSEcCtD
